Sales M E, Borda E S
Centro de Estudios Farmacológicos y Botánicos (CEFYBO), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina.
Can J Physiol Pharmacol. 1994 May;72(5):456-62. doi: 10.1139/y94-066.
Two different mechanisms of regulation in uterine beta-adrenergic receptors in allogeneic pregnancy (AP) and syngeneic pregnancy (SP) are described in this work. Firstly we noted changes in beta-adrenergic sensitivity to isoproterenol in AP, while in SP differences in uterine reactivity to isoproterenol were found. In binding assays with the beta-antagonist [3H]dihydroalprenolol, changes in beta-receptor affinity were seen in AP, while in SP the maximal number of binding sites is altered. In addition, there are differences in uterine concentrations of cyclic AMP in both types of pregnancies as well as in the nucleotide response to isoproterenol. The differences in the reactivity and expression of uterine beta-adrenoceptors in both types of pregnancies may be due to a distinctive immunological role of the semiallogeneic fetus in AP.
本研究描述了同种异体妊娠(AP)和同基因妊娠(SP)中子宫β-肾上腺素能受体的两种不同调节机制。首先,我们注意到AP中β-肾上腺素能对异丙肾上腺素的敏感性发生了变化,而在SP中发现了子宫对异丙肾上腺素反应性的差异。在用β-拮抗剂[3H]二氢阿普洛尔进行的结合试验中,AP中可见β-受体亲和力的变化,而在SP中结合位点的最大数量发生了改变。此外,两种妊娠类型中子宫环磷酸腺苷的浓度以及对异丙肾上腺素的核苷酸反应也存在差异。两种妊娠类型中子宫β-肾上腺素能受体反应性和表达的差异可能归因于AP中半同种异体胎儿独特的免疫作用。